Taking the aforementioned reports into consideration, this study proposed a hypothesis that CpG-ODNs might affect RKI in cervical cancer with the involvement of the regulation of the PARP1/XRCC1 axis, in hope of finding a novel direction for protection against RKI in cervical cancer. This evidence concerns the gene XRCC1 and cervical carcinoma.